Business Law and Corporate Law

Subscribe
Business law and corporate law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics that involve business and corporate law produced by specialists working in this area every day.
Article
The Hidden Dilution Trap for Founders in Post-Money SAFEs
Post-money SAFEs can create unexpected founder dilution when startups raise multiple SAFE rounds. Unlike pre-money SAFEs where later investors dilute everyone proportionally, post-money SAFEs protect investor ownership percentages and shift all dilution burden onto founders. Understanding this critical difference before signing can prevent costly surprises at your first priced financing.
United States Commercial
GU
Gesmer Updegrove LLP
Article
How The BIOSECURE Act Will Create New Contracting And Supply-Chain Disputes
The BIOSECURE Act has moved from legislative possibility to operational reality. Enacted as part of the Fiscal Year 2026 National Defense Authorization Act, the law restricts federal agencies, federal contractors, and recipients of certain federal funds from procuring or using biotechnology equipment or services supplied by designated “biotechnology companies of concern.”
United States Commercial
IG
IR Global
Article
CLIENT ALERT: New York’s Freelance Isn’t Free Acts—What Businesses Need To Know
New York businesses that engage freelancers must now navigate two overlapping Freelance Isn't Free Acts—one enacted by New York City in 2017 and another by New York State in 2024. How do these statutes differ in their compliance requirements, enforcement mechanisms, and litigation risks, and what practical steps should companies take to avoid exposure under both regimes?
United States Commercial
ST
Sher Tremonte
See more
Article
Artificial Intelligence, Privilege, And Work Product: Emerging Risks In The Life Sciences Industry
Recent court decisions reveal conflicting approaches to whether communications with generative AI tools waive attorney-client privilege or work product protection, creating significant uncertainty for companies handling sensitive legal and proprietary information. Life sciences companies face heightened risks as they increasingly rely on AI tools while managing confidential clinical data, regulatory strategies, and intellectual property that may become subject to discovery in future litigation.
United States Commercial
AP
Arnold & Porter
See more
See more
Article
Updating The Boilerplate And Post-Signature Governance
AI vendor contracts require more than standard SaaS boilerplate—they demand AI-specific updates to representations, warranties, indemnities, and liability caps, plus robust post-signature governance frameworks. This article examines how traditional contract provisions must be recalibrated to address the unique opacity, autonomy, and evolving nature of AI systems, while establishing operational monitoring and compliance mechanisms that give contracts lasting force.
United States Commercial
Wa
Ward and Smith, P.A.
See more
Article
The Hidden Dilution Trap for Founders in Post-Money SAFEs
Post-money SAFEs can create unexpected founder dilution when startups raise multiple SAFE rounds. Unlike pre-money SAFEs where later investors dilute everyone proportionally, post-money SAFEs protect investor ownership percentages and shift all dilution burden onto founders. Understanding this critical difference before signing can prevent costly surprises at your first priced financing.
United States Commercial
GU
Gesmer Updegrove LLP
Article
The Letter Of Intent Isn’t A Done Deal: What Every Seller Needs To Know Before Signing
A letter of intent marks a critical juncture in any M&A transaction, yet many sellers sign without fully grasping the binding provisions that can significantly diminish their negotiating leverage. Understanding which LOI terms are enforceable from the moment of signature—and what protective language to negotiate before signing—can mean the difference between closing at your business's true value or spending months in a defensive posture as the deal terms erode.
United States Commercial
BB
Beresford Booth
See more